Researchers at The Wistar Institute and the University of South Florida have advanced a novel compound that specifically targets the endoplasmic reticulum (ER) stress response that is frequently hyperactivated in cancer and promotes survival of cancer cells during stressful conditions. The new compound has unique chemical properties that allow for precise activation and can be used for tracking its activity in vivo thanks to the emission of fluorescence.
Research was published online in the Journal of Medicinal Chemistry.
The ER is a cellular structure that oversees protein folding and assembly, and it activates stress response mechanisms in response to the accumulation of misfolded proteins or other stressful conditions, including low oxygen.
“Certain cancers rely on the protective role of the ER stress response to sustain their growth in stressful environmental conditions,” said Chih-Chi Andrew Hu, Ph.D., associate professor in Wistar’s Immunology, Microenvironment & Metastasis Program, and co-lead author on the study with Juan R. Del Valle, Ph.D., from the University of South Florida. “We and other groups showed that genetically and pharmacologically targeting the ER is a very effective way to attack various tumors.”
The Hu lab has been actively advancing a research program for development of compounds to block vital functions of the ER stress response, specifically inhibitors of the IRE1 protein that senses the ER stress and responds by activating a cascade of cellular events. In addition to inducing tumor cell apoptosis, these compounds activate antitumor T-cell function and inhibit tumor-associated immunosuppressive cells in vivo in mouse models, resulting in tumor shrinkage.
“This class of inhibitors has shown therapeutic promise in several cancer types, including chronic lymphocytic leukemia and Burkitt lymphoma,” said Hu. “Therefore, we are very interested in advancing them to the clinic.”
In this study, through a series of chemical modifications, Hu and collaborators created a molecule called PC-D-F07 that is pharmacologically inactive and requires UV irradiation to be “turned on” and converted into the active D-F07, which is a very potent inhibitor of IRE-1 function.
The novel prodrug strategy enhances the efficacy of IRE-1 inhibitors and allows fine control of their activity at a precise time and location by UV irradiation. Importantly, once active, D-F07 emits fluorescence that can be tracked in cells and potentially in vivo, providing a real-time therapy readout. This new strategy for stimulus-mediated release of pharmacological activity provides a promising platform to target the ER stress response for anticancer therapy and for developing other potent inhibitors.
The Latest on: Cancer treatment
via Google News
The Latest on: Cancer treatment
- NCCN Shares New Guidance Principles for Vaccinating People with Cancer Against COVID-19on January 22, 2021 at 4:25 am
The National Comprehensive Cancer Network ® (NCCN ®) put out new information today to provide guidance for COVID-19 vaccinations in people with cancer. The nonprofit alliance of leading cancer centers ...
- Make A Wish gives camper to Hays girl undergoing cancer treatmenton January 22, 2021 at 4:01 am
Make A Wish couldn't grant Sophia Linenberger, a junior at Thomas More Prep-Marian, her original wish but managed to come through to fulfill another dream. Sophia received a 2021 Coleman Lantern ...
- Cancer Treatment & Research: Cancer research startups seek fertile ground in South Floridaon January 22, 2021 at 3:15 am
The push to make South Florida a hub for cancer research companies has been ongoing for nearly two decades, and major signs of progress are surfacing.
- New combination of immunotherapies shows great promise for treating lung canceron January 21, 2021 at 11:56 pm
McMaster University researchers have established in lab settings that a novel combination of two forms of immunotherapy can be highly effective for treating lung cancer, which causes more deaths than ...
- Genomic test has lower prognostic accuracy in minority patients with breast canceron January 21, 2021 at 9:37 pm
Black women have higher recurrence and mortality rates than non-Hispanic white women for certain types of breast cancer, according to a University of Illinois Chicago researcher's study published ...
- Dustin Diamond completes first round of chemotherapy for cancer treatmenton January 21, 2021 at 6:00 pm
Former "Saved by the Bell" star Dustin Diamond is making progress in his fight against cancer. A representative for the actor said on Thursday that Diamond, known for playing Samuel "Screech" Powers ...
- Dustin Diamond undergoing chemotherapy treatments for canceron January 21, 2021 at 5:13 pm
Original “Saved by the Bell” star Dustin Diamond has begun undergoing chemotherapy treatments after being diagnosed with cancer, according to his representative ...
- Target of new cancer treatment valid for breast as well as blood cancerson January 21, 2021 at 8:22 am
One more piece of the puzzle has fallen into place behind a new drug whose anti-cancer potential was developed at the University of Alberta and is set to begin human trials this year, thanks to newly ...
- Preop Chemo Misses Mark in Pancreatic Canceron January 21, 2021 at 8:02 am
Two different preoperative chemotherapy regimens for pancreatic cancer failed to improve survival as compared with historical outcomes with adjuvant therapy, a randomized trial showed. A modified ...
- Stand Up To Cancer Announces $3.25 Million In Grants For Research To Improve Treatment Of Head And Neck Cancerson January 21, 2021 at 6:23 am
PRNewswire/ -- Stand Up To Cancer® (SU2C) today announced $3.25 million in grants from four national nonprofits to fund research to find new treatments for head and neck cancers, which are newly ...
via Bing News